Effectiveness of Elbasvir and Grazoprevir Combination, With or Without Ribavirin, for Treatment-Experienced Patients With Chronic Hepatitis C InfectionPaul Y. Kwo, Barbara Haber, Marı́a Buti et al.|Gastroenterology|2016Cited by 173
P0886 : Efficacy and safety of grazoprevir/elbasvir +/- RBV for 12 weeks in patients with HCV G1 or G4 infection who previously failed peginterferon/RBV: C-edge treatment-experienced trialPaul Y. Kwo, Barbara Haber, E. Gane et al.|Journal of Hepatology|2015Cited by 39
901f Efficacy and Safety of Grazoprevir/Elbasvir ± Ribavirin (RBV) for 12 or 16 Weeks in Patients With HCV G1, G4, or G6 Infection Who Previously Failed Peginterferon/RBV: C-EDGE Treatment-Experienced TrialPaul Y. Kwo, Barbara Haber, Edward Gane et al.|Gastroenterology|2015Cited by 16